PUBLICATIONS & GUIDELINES

PUBLICATIONS

DATE TITLE
08/07/2019 Nicola J. Adderley, Anuradhaa Subramanian, Krishnarajah Nirantharakumar, Andreas Yiangou, Krishna M. Gokhale, Susan P. Mollan, Alexandra J. Sinclair. Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom. JAMA Neurol. Published online July 08, 2019. doi:10.1001/jamaneurol.2019.1812
15/03/2019 Mollan SP, Hemmings K, Herd C, Denton A, Williamson M, Sinclair A. Research priorities for idiopathic intracranial hypertension. (BMJ Open. 2019 Mar 15;9(3):e026573)
01/03/2019 Mollan S, Aguiar M, Evison F, Frew E, Sinclair AJ. The expanding burden of idiopathic intracranial hypertension. Eye (Lond). 2019 Mar;33(3):478-485
12/02/2019 O’Reilly MW, Westgate CSJ, Hornby C, Botfield H, Taylor AE, Markey K, Mitchell JL, Scotton WJ, Mollan JP, Yiangou A, Jenkinson C, Gilligan LC, Sherlock M, Gibney J, Tomlinson JW, Lavery GG, Hodson DJ, Arlt W, Sinclair AJ. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 2019 Feb 12. pii: 125348. doi: 10.1172/jci.insight.125348
23/08/2017 Botfield HF, Uldall MS, Westgate CSJ, Mitchell JL, Hagen SM, Gonzalez AM, Hodson DJ, Jensen RH, Sinclair AJ. A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus. Sci Transl Med. 2017 Aug 23;9(404)
15/05/2015 Mulla Y, Markey KA, Woolley RL, Patel S, Mollan SP, Sinclair AJ. Headache determines quality of life in idiopathic intracranial hypertension. J Headache Pain. 2015;16:521

  SUBSCRIBE TO UPDATES

Disclaimer. Copyright © Invex Therapeutics. All rights reserved. Site developed by NFIC Services.